Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELPERCATINIB vs SENSIPAR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELPERCATINIB vs SENSIPAR: Safety Overview

Metric SELPERCATINIB SENSIPAR
Total FAERS Reports 1,084 577
Deaths Reported 160 82
Death Rate 14.8% 14.2%
Hospitalizations 342 52
Average Patient Age 63.0 yrs 62.8 yrs
% Female Patients 56.7% N/A
FDA Approval Date Apr 10, 2024 N/A
Manufacturer Eli Lilly and Company N/A
Route ORAL N/A
Marketing Status Prescription N/A